 Home > Biochemical Engineering > Polypeptide > Retatrutide research-grade peptide, purity99%

Retatrutide research-grade peptide, purity99% buy - large image1

Retatrutide research-grade peptide, purity99%

Name: Retatrutide research-grade peptide, purity99%
Brand: LianTuo Technology
SKU: pr2608031283
Price: 90 USD
Availability: InStock

Unit Price: Get Latest Price 

Grade:

Pharmaceutical Grade

Content:

99%

Port:

GuangZhou

Brand:

LianTuo Technology

Packaging:

5mg*10vials/10mg*10vials

Price valid (until):

2026-09-03

Contact Supplier

 Chat Now

Liantuo Technology Co., Ltd.

Company Type:

Trader

Location:

China

Payment Terms:

TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Qualification:

Main Products:

beaty prodt

 Visit Store

Product Details
Seller Information

Description

Product Detail

Retatrutide research-grade peptide sample, HPLC purity ≥99%, white lyophilized powder. Individually sealed vial packaging, 10mg net weight per vial. Each batch passes full-process standardized quality inspection. We hold sufficient ready stock to ensure stable supply.

Items Specifications

Retatrutide 5mg*10vials

10mg*10vials

15mg*10vials

Basic Info

Product Name:
Retatrutide;RT10;RT15;RT20,retatrutide

Categories:
Polypeptide

Research

Class:
Triple agonist — GCGR, GIPR, GLP-1R

Status:
Investigational (Phase 3)

Mechanism:
Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

EC50 (Human GCGR):
5.79 nM

EC50 (Mouse GIPR):
0.191 nM

EC50 (Mouse GLP1R):
0.794 nM

EC50 (Mouse GCGR):
2.32 nM

EC50 (Human GLP1R):
0.775 nM

EC50 (Human GIPR):
0.0643 nM

Source:
Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

Clinical Development:
NCT04881760; NCT05882045; NCT06354660

References

ChEMBL:
CHEMBL5095485

DrugBank:
DB18993

KEGG DRUG:
D12430

PubChem:
PubChem

Literature:
NEJM: Jastreboff et al. (2023) — Phase 2 Trial; FDA Drugs@FDA

Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Seller Information

Business Type:
Trader

Main Products:
beaty prodt

Location:
Room 1664, 3rd Floor, No. 1-2, East Lane, Yuancun Sanheng Road, Tianhe District, Guangzhou City

Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Total Annual Revenue:
Less than $1 million

Total Employees:
11-50

Year of Establishment:
2026
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

Hot Searches: calcium salmon; hydrofluoroether solvent; 1 8 cineole; active pharmaceutical ingredients bestellen; where to buy semax; buying adrenochrome; buy nandrolone decanoate; retatrutide buy online usa; polypropylene price per ton in nigeria 2026; methylamine price per gallon; buy reta online; xylene price

Items	Specifications
Retatrutide	5mg*10vials
	10mg*10vials
	15mg*10vials

Retatrutide research-grade peptide, purity99%

Product Details

Seller Information

More from this Seller